Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCP2 | P22307 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19646592 | 0.89 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL16812947 | 0.88 | SCP2 (0.74) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL62370 | 0.86 | SCP2 (0.77) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL26434823 | 0.85 | SCP2 (0.76) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL3501312 | 0.85 | SCP2 (0.82) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL26434988 | 0.84 | SCP2 (0.75) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL14267417 | 0.83 | SCP2 (1.00) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL17230446 | 0.82 | MEN1 (0.67) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL13201656 | 0.81 | SCP2 (0.76) | SCP2MEN1NPC1POLBRAB9A | |
| SCHEMBL7812704 | 0.81 | SCP2 (0.93) | SCP2MEN1NPC1POLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009659-A1 | DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS | ÉCOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2025-01-09 | — | — | US | disclosed |
| EP-4433449-A1 | DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS | Université de Rennes (FR) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023083983-A9 | DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS | UNIVERSITE DE RENNES (FR) | 2024-07-18 | — | — | WO | disclosed |
| WO-2023083983-A1 | DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS | UNIVERSITE DE RENNES (FR) | 2023-05-19 | — | — | WO | disclosed |
| EP-4180410-A1 | DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS | Université de Rennes (FR) | 2023-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009659-A1 | DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS | LCAT, FNTA, LIPA | SCP2 244/4885MEN1 3847/4885NPC1 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.